Contact TALLC
Get In Touch
More Info
We are a pre-clinical stage pharmaceutical company using our proprietary NCE to treat acute and chronic inflammation. We will offer our products for licensing post Ph II studies in high unmet need indications.
Address: 500 Cartier Blvd W
Laval (Québec)
Canada H7V 5B7
Phone: 514 883 3447
NEWS
TALLC issues new Corporate Presentation
Dr. Damon Smith at Biotech Show Case
TALLC at the Ophthalmology Innovation Summit
TALLC Corporation Announces Grant of New SmartCelle Patent for Enhanced Ocular Delivery of TA-A001
Tetra Bio-Pharma and Altus Formulation Form New Company “TALLC” to Exploit TA-A001
TALLC Innovation in Vision
© TALLC Inc. 2020